Skip to main content
. 2015 Mar 15;8(3):3671–3680.

Table 1.

Characteristics of subjects in eligible studies

Studies Country Age (year) Type of Mn measurement Sample specimen Breast cancer Healthy controls Weight (%) SMD (95% CI) Quality score



Breast cancer Healthy control N Mn concentration (mean ± SD) N Mn concentration (mean ± SD)
Bai 2000 China 32~65 32~65 ICP-AAS Hair 38 1.01 ± 0.62 ng/g 38 6.78 ± 4.19 ng/g 9.11 -1.93 (-2.47, -1.38) 6
Kilic 2004 Turkey 53±9 55 ± 7 GFAAS Hair 26 0.67 ± 0.52 μg/g 27 1.66 ± 0.4 μg/g 8.97 -2.12 (-2.80, -1.44) 7
Dai 2005 China 28~58 23~68 ICP-AAS Serum 54 0.18 ± 0.07 μmol/l 56 1.44 ± 0.84 μmol/l 9.18 -2.10 (-2.56, -1.63) 7
Liang 2005 China 32~68 22~58 ICP-AAS Serum 28 0.08 ± 0.01 μmol/l 22 1.52 ± 0.88 μmol/l 8.88 -2.47 (-3.22, -1.73) 7
Wu 2006 China NA NA ICP-AES Serum 25 5.5 ± 0.47 μg/l 26 9.09 ± 1.25 μg/l 8.63 -3.77 (-4.70, -2.85) 5
Li 2006 China 20~70 20~70 ICP-AAS Serum 78 1.71 ± 0.11 μg/dl 61 1.65 ± 0.18 μg/dl 9.28 0.41 (0.08, 0.75) 7
Li 2008 China 49.9 ± 10.7 20~70 ICP-AAS Serum 93 1.75 ± 0.16 μg/dl 81 1.64 ± 0.17 μg/dl 9.30 0.67 (0.36, 0.97) 7
Joo 2009 Korea 47.1 ± 9.6 47.8 ± 5.1 ICP-AAS Hair 40 0.21 ± 0.04 μg/g 144 0.44 ± 0.0 μg/g 9.11 -4.08 (-4.63, -3.54) 7
Wang 2010 China 25~60 26~60 ICP-AAS Serum 25 0.24 ± 0.41 μmol/l 260 0.22 ± 0.2 μmol/l 9.23 0.10 (-0.31, 0.51) 7
Cihan 2011 Turkey 50.3 ± 8.8 47.4 ± 10.1 ICP-AAS Hair 52 0.989 ± 0.924 μg/g 52 0.863 ± 0.675 μg/g 9.25 0.16 (-0.23, 0.54) 7
Feng 2012 China 48.7 ± 8.4 47.2 ± 7.6 GFAAS Serum 56 8.3 ± 1.57 μg/l 20 10.95 ± 1.14 μg/l 9.07 -1.80 (-2.39, -1.21) 7

ICP-AAS, inductively coupled plasma-atomic absorption spectrometry. ICP-AES, inductively coupled plasma-atomic emission spectrometry. GFAAS, graphite furnace atomic absorption spectroscopy.